Cancer News and Research

Latest Cancer News and Research

Viewpoints: Dubious ad on Romney's role in cancer death; British health plan has problems of its own

He sits at a kitchen table, nursing a cup of coffee, talking about what happened after Bain Capital closed down his steel plant in 2001. He lost his job; his family lost its health insurance. His wife felt lousy but didn't go to the doctor, to spare the family worry and expense. When she finally ended up in the hospital, the diagnosis was cancer. She had 22 days to live.

9 Aug 2012

Researchers develop and test new prostate cancer screening method

Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more likely to have aggressive prostate cancer despite negative biopsies.

9 Aug 2012

MedPage Today, CollabRx sign license agreement for Oncology Next

Tegal Corporation today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health, Inc.'s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.

9 Aug 2012

Berlin Heart EXCOR Pediatric Ventricular Assist Device proves effective and life-saving

A tiny heart pump that maintains blood flow in babies and small children with serious heart failure proved effective and life-saving in a pioneering study involving 17 institutions led by Texas Children's Hospital and Baylor College of Medicine (BCM).

9 Aug 2012

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech provided today an update on the clinical development program of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS).

9 Aug 2012

Inaugural event of National Women's Survivors Convention to be held in Nashville

In August 2013, Nashville will be the host city to the National Women's Survivors Convention (NWSC), a first of its kind national event designed to celebrate women cancer survivors.

9 Aug 2012

VA agrees to move forward on CT screening for veterans at high risk for lung cancer

Today, Lung Cancer Alliance (LCA) announced that the Department of Veterans Affairs (VA) has agreed to move forward on CT screening for veterans at high risk for lung cancer. This was communicated to Laurie Fenton Ambrose, LCA President & CEO in written correspondence by VA Under Secretary for Health Dr. Robert A. Petzel.

9 Aug 2012

Amgen announces decision to stop ganitumab Phase 3 trial in advanced pancreatic cancer

Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.

9 Aug 2012

VEGF inhibitor fails to improve nonsquamous NSCLC overall survival

Adding motesanib to carboplatin–paclitaxel does not boost overall survival in patients with advanced nonsquamous non-small-cell lung cancer, including those with adenocarcinoma, say MONET1 investigators.

8 Aug 2012

Progression-free NSCLC survival boosted by dacomitinib

In patients with non-small-cell lunch cancer, dacomitinib confers a significant progression-free survival benefit over erlotinib across a range of clinical and molecular subgroups, the results of an international study indicate.

8 Aug 2012

Increases in NSCLC survival 'an artefact of PET assessment'

There has been no increase in survival among non-small-cell lung cancer patients in recent years, with evidence suggesting otherwise likely due to positron emission tomography-induced stage migration and selection bias, say US scientists.

8 Aug 2012

Lung cancer patients can be screened for ALK-inhibitor suitability

Anaplastic lymphoma kinase gene status in patients with lung adenocarcinoma can be determined non-invasively using circulating tumor cells, research shows.

8 Aug 2012

Elderly NSC lung cancer patients benefit from concurrent chemoradiation

Fit older adults with locally advanced non-small-cell lung cancer reap similar benefit from concurrent chemoradiation with etoposide and cisplatin as younger patients, but experience higher rates of hospitalization and toxicity, research shows.

8 Aug 2012

Folate, excision biomarkers not predictive for small-cell lung cancer response

Biomarkers associated with the folate metabolism and excision repair pathways are not sufficiently prognostic to aid chemotherapy decisions for patients with extensive-stage disease small-cell lung cancer, results of a phase III trial show.

8 Aug 2012

Work solvent-related brain tumor concerns allayed

There is no consistent evidence for increased risk for glioma or meningioma following occupational exposure to chlorinated solvents, say researchers.

8 Aug 2012

Interface zone fibroblasts play key role in gastric cancer

Interface zone fibroblasts in gastric adenocarcinoma promote the invasion, migration, and proliferation of cancer cells, as well as prevent apoptosis, to a greater degree than normal or tumor zone fibroblasts, say researchers.

8 Aug 2012

Researchers call for digital rectal exam revival

Rates of digital rectal examination are low in clinical practice and levels of sufficient training in the technique may be in decline, the results of a US study suggest.

8 Aug 2012

Hospice cancer patients adhere well to pain meds

Study results from the midwest USA indicate that hospice-treated older individuals with cancer are highly adherent to pain medication, but that as they become more comfortable, adherence wanes.

8 Aug 2012

High BMI linked to poor outcomes after prostatectomy and ADT

Men initiating androgen deprivation therapy after radical prostatectomy are more likely to experience poor outcomes if they are overweight or obese, report researchers.

8 Aug 2012

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones.

8 Aug 2012